Solid lipid nanoparticles loaded with retinoic acid and lauric acid as an alternative for topical treatment of acne vulgaris

Journal of Nanoscience and Nanotechnology

Volumn 15, Issue 1, 2015, Pages 792-799

  Silva, Elton Luiz ^a   Carneiro, Guilherme ^a,b   De Araújo, Lidiane Advíncula ^a   Vaz Trindade, Mariana De Jesus ^a   Yoshida, Maria Irene ^a   Oréfice, Rodrigo Lambert ^a   Farias, Luis De Macêdo ^a   De Carvalho, Maria Auxiliadora Roque ^a   Dos Santos, Simone Gonҫalves ^a   Goulart, Gisele Assis Castro ^a   Alves, Ricardo José ^a   Ferreira, Lucas Antônio Miranda ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Federal University of Jequitinhonha and Mucuri Valleys   (Brazil)

Author keywords

Acne; Antibacterial activity; Lauric acid; Retinoic acid; Solid lipid nanoparticles; Topical treatment

Indexed keywords

BACTERIA; DIFFERENTIAL SCANNING CALORIMETRY; DRUG INTERACTIONS; EFFICIENCY; ENCAPSULATION; NANOPARTICLES; SATURATED FATTY ACIDS; SKIN; X RAY DIFFRACTION;

ACNE; ANTI-BACTERIAL ACTIVITY; LAURIC ACID; RETINOIC ACIDS; SOLID LIPID NANOPARTICLE (SLN); TOPICAL TREATMENTS;

DRUG DELIVERY;

ANTIINFECTIVE AGENT; LAURIC ACID; LAURIC ACID DERIVATIVE; NANOPARTICLE; RETINOIC ACID;

ACNE VULGARIS; CHEMISTRY; DRUG EFFECTS; DRUG STABILITY; MICROBIAL SENSITIVITY TEST; PARTICLE SIZE; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; DRUG STABILITY; LAURIC ACIDS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS; TRETINOIN;

EID: 84920666889     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2015.9184     Document Type: Article

References (29)

1. L. F. Eichenfield, J. F. Fowler, Jr, R. G. Fried, S. F. Friedlander, M. L. Levy, and G. F. Webster, Semin. Cutan. Med. Surg. 29, 13 (2010).
2. H. Gollnick, Drugs 63, 1579 (2003).
3. C. N. Ellis, L. E. Millikan, E. B. Smith, D. M. Chalker, L. J. Swinyer, I. H. Katz, R. S. Berger, O. H. Mills, Jr, M. Baker, M. Verschoore, and C. Loesche, Br. J. Dermatol. 139, 41 (1998).
4. G. F. Webster, J. Am. Acad. Dermatol. 39, S38 (1998).
5. H. Gollnick and M. Schramm, Dermatology 196, 119 (1998).
6. H. Kim, N. Kim, S. Jung, J. Mun, J. Kim, B. Kim, J. Lee, H. Ryoo, and H. Jung, Br. J. Dermatol. 162, 497 (2010).
7. J. Varani, H. Fligiel, J. Zhang, M. N. Aslam, Y. Lu, L. A. Dehne, and E. T. Keller, Arch. Dermatol. Res. 295, 255 (2003).
8. J. W. Fluhr, M. P. Vienne, C. Lauze, P. Dupuy, W. Gehring, and M. Gloor, Dermatology 199, 57 (1999).
9. G. A. Castro and L. A. Ferreira, Expert Opin Drug Deliv. 5, 665 (2008).
10. A. A. Date, B. Naik, and M. S. Nagarsenker, Skin Pharmacol. Physiol. 19, 2 (2006).
11. V. Jenning and S. H. Gohla, J. Microencapsul. 18, 149 (2001).
12. G. A. Castro, A. L. Coelho, C. A. Oliveira, G. A. Mahecha, R. L. Orefice, and L. A. Ferreira, Int. J. Pharm. 381, 77 (2009).
13. G. A. Castro, R. L. Orefice, J. M. Vilela, M. S. Andrade, and L. A. Ferreira, J. Microencapsul. 24, 395 (2007).
14. H. Gollnick, W. Cunliffe, D. Berson, B. Dreno, A. Finlay, J. J. Leyden, A. R. Shalita, and D. Thiboutot, J. Am. Acad. Dermatol. 49, S1 (2003).
15. D. Thiboutot, H. Gollnick, V. Bettoli, B. Dreno, S. Kang, J. J. Leyden, A. R. Shalita, V. T. Lozada, D. Berson, A. Finlay, C. L. Goh, M. I. Herane, A. Kaminsky, R. Kubba, A. Layton, Y. Miyachi, M. Perez, J. P. Martin, E. S. M. Ramos, J. A. See, N. Shear, and J. Wolf, Jr, J. Am. Acad. Dermatol. 60, S1 (2009).
16. D. R. Drake, K. A. Brogden, D. V. Dawson, and P. W. Wertz, J. Lipid Res. 49, 4 (2008).
17. T. Nakatsuji, M. C. Kao, J. Y. Fang, C. C. Zouboulis, L. Zhang, R. L. Gallo, and C. M. Huang, J. Invest. Dermatol. 129, 2480 (2009).
18. D. Yang, D. Pornpattananangkul, T. Nakatsuji, M. Chan, D. Carson, C. M. Huang, and L. Zhang, Biomaterials 30, 6035 (2009).
19. G. Carneiro, E. L. Silva, L. A. Pacheco, E. M. de Souza-Fagundes, N. C. Correa, A. M. de Goes, M. C. de Oliveira, and L. A. Ferreira, Int. J. Nanomedicine 7, 6011 (2012).
20. A. Mehta, A. M. Oeser, and M. G. Carlson, J. Chromatogr. B Biomed. Sci. Appl. 719, 9 (1998).
21. S. J. Booth, J. L. Johnson, and T. D. Wilkins, Antimicrob. Agents Chemother. 11, 718 (1977).
22. R. H. Muller, M. Radtke, and S. A. Wissing, Adv. Drug Deliv. Rev. 54, S131 (2002).
23. S. J. Lim and C. K. Kim, Int. J. Pharm. 243, 135 (2002).
24. L. Hu, X. Tang, and F. Cui, J. Pharm. Pharmacol. 56, 1527 (2004).
25. R. H. Muller, K. Mader, and S. Gohla, Eur. J. Pharm. Biopharm. 50, 161 (2000).
26. M. T. Campanha, E. M. Mamizuka, and A. M. Carmona-Ribeiro, J. Lipid Res. 40, 1495 (1999).
27. E. M. Mamizuka and A. M. Carmona-Ribeiro, Cationic Liposomes as Antimicrobial Agents, Communicating Current Research and Educational Topics and Trends in Applied Microbiology 636 (2007).
28. E. C. Clemens, J. D. Chan, J. B. Lynch, and T. H. Dellit, Diagn. Microbiol. Infect. Dis. 71, 408 (2011).
29. Y. Ando, H. Miyamoto, I. Noda, F. Miyaji, T. Shimazaki, Y. Yonekura, M. Miyazaki, M. Mawatari, and T. Hotokebuchi, Biocontrol. Sci. 15, 15 (2010).